Literature DB >> 31242368

What Is Safe Sedation in the ICU?

Douglas B Coursin1, Yoanna Skrobik1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31242368     DOI： 10.1056/NEJMe1906522

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  [First-line sedation with dexmedetomidine-end of the story?]

Authors:  Björn Weiss
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-04       Impact factor: 0.840

2.  Inhibitory Effects of Dexmedetomidine and Propofol on Gastrointestinal Tract Motility Involving Impaired Enteric Glia Ca2+ Response in Mice.

Authors:  Yansong Li; Yubo Wang; Haiqing Chang; Bo Cheng; Jiwen Miao; Shuang Li; Hao Hu; Liyu Huang; Qiang Wang
Journal:  Neurochem Res       Date:  2021-03-03       Impact factor: 3.996

3.  Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based Consensus.

Authors:  Frank A Rasulo; Philip Hopkins; Francisco A Lobo; Pierre Pandin; Basil Matta; Carla Carozzi; Stefano Romagnoli; Anthony Absalom; Rafael Badenes; Thomas Bleck; Anselmo Caricato; Jan Claassen; André Denault; Cristina Honorato; Saba Motta; Geert Meyfroidt; Finn Michael Radtke; Zaccaria Ricci; Chiara Robba; Fabio S Taccone; Paul Vespa; Ida Nardiello; Massimo Lamperti
Journal:  Neurocrit Care       Date:  2022-07-27       Impact factor: 3.532

4.  ICU Physicians' Perception of Patients' Tolerance Levels in Light Sedation Impacts Sedation Practice for Mechanically Ventilated Patients.

Authors:  Yichun Gong; Huilong Yang; Junqing Xie; Jingtao Liu; Jianxin Zhou; Penglin Ma
Journal:  Front Med (Lausanne)       Date:  2019-10-18

Review 5.  Sedation in the Intensive Care Unit.

Authors:  Valerie Page; Cathy McKenzie
Journal:  Curr Anesthesiol Rep       Date:  2021-04-24

6.  Effect of Sedatives on In-hospital and Long-term Mortality of Critically Ill Patients Requiring Extended Mechanical Ventilation for ≥ 48 Hours.

Authors:  Hannah Lee; Seongmi Choi; Eun Jin Jang; Juhee Lee; Dalho Kim; Seokha Yoo; Seung-Young Oh; Ho Geol Ryu
Journal:  J Korean Med Sci       Date:  2021-08-30       Impact factor: 2.153

7.  Design of Clinical Trials Evaluating Sedation in Critically Ill Adults Undergoing Mechanical Ventilation: Recommendations From Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research (SCEPTER) Recommendation III.

Authors:  Denham S Ward; Anthony R Absalom; Leanne M Aitken; Michele C Balas; David L Brown; Lisa Burry; Elizabeth Colantuoni; Douglas Coursin; John W Devlin; Franklin Dexter; Robert H Dworkin; Talmage D Egan; Doug Elliott; Ingrid Egerod; Pamela Flood; Gilles L Fraser; Timothy D Girard; David Gozal; Ramona O Hopkins; John Kress; Mervyn Maze; Dale M Needham; Pratik Pandharipande; Richard Riker; Daniel I Sessler; Steven L Shafer; Yahya Shehabi; Claudia Spies; Lena S Sun; Avery Tung; Richard D Urman
Journal:  Crit Care Med       Date:  2021-10-01       Impact factor: 9.296

8.  Physical Restraint Use in Intensive Care Units: Exploring the Decision-Making Process and New Proposals. A Multimethod Study.

Authors:  María Acevedo-Nuevo; María Teresa González-Gil; María Concepción Martin-Arribas
Journal:  Int J Environ Res Public Health       Date:  2021-11-11       Impact factor: 3.390

9.  Prospective comparison of acupuncture with sham acupuncture to determine impact on sedation and analgesia in mechanically ventilated critically ill patients (PASSION study): protocol for a randomised controlled trial.

Authors:  Yuzhuo Zhang; Guang Yang; Jinyi Wei; Fangliang Chen; Min-Zhou Zhang; Shuai Mao
Journal:  BMJ Open       Date:  2022-08-30       Impact factor: 3.006

10.  Effect of sedation with dexmedetomidine or propofol on gastrointestinal motility in lipopolysaccharide-induced endotoxemic mice.

Authors:  Haiqing Chang; Shuang Li; Yansong Li; Hao Hu; Bo Cheng; Jiwen Miao; Hui Gao; Hongli Ma; Yanfeng Gao; Qiang Wang
Journal:  BMC Anesthesiol       Date:  2020-09-07       Impact factor: 2.217
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.